Related Topics News -

     
 Title only   |   Print    Next page > 
     
《大行》交銀國際:南向資金近月主力配置集中醫療和金融板塊 反映對高息防禦價值重視

2025-07-04T  
樂普生物折讓近11%配售H股 淨籌逾4.6億元

2025-07-04T  
樂普生物候選藥MRG003於ASCO年會公布臨床研究結果

2025-06-01T  
樂普生物獲發H股全流通申請備案通知書

2025-05-28T  
《業績》樂普生物全年虧損擴大至4.11億人幣 不派末期息

2025-03-27T  
樂普生物重新提交治療鼻咽癌新藥上市申請

2025-03-04T  
樂普生物向ArriVent授予創新型ADC MRG007藥物獨家許可

2025-01-22T  
樂普生物建議變更核數師

2024-11-27T  
樂普生物候選藥物MRG003新藥上市申請獲藥監局受理

2024-09-27T  
《業績》樂普生物-B半年虧損擴大至1.92億元人民幣

2024-08-21T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.